0001083522-15-000029.txt : 20150511 0001083522-15-000029.hdr.sgml : 20150511 20150508190952 ACCESSION NUMBER: 0001083522-15-000029 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150511 DATE AS OF CHANGE: 20150508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JONES SODA CO CENTRAL INDEX KEY: 0001083522 STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080] IRS NUMBER: 911696175 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-166556 FILM NUMBER: 15848488 BUSINESS ADDRESS: STREET 1: 1000 1ST AVE S. STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98134 BUSINESS PHONE: 206 624-3357 MAIL ADDRESS: STREET 1: 1000 1ST AVE S. STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98134 FORMER COMPANY: FORMER CONFORMED NAME: URBAN JUICE & SODA CO LTD /WY/ DATE OF NAME CHANGE: 19990407 424B3 1 jsda-20150508x8k.htm 424B3 Prospectus Supplement No1

 

 

 

 

 

 

 

 

PROSPECTUS SUPPLEMENT NO. 1

Filed Pursuant to Rule 424(b)(3)

(To Prospectus dated April 3, 2015)

Registration No. 333-166556

 

 

JONES SODA CO.

 

3,057,500 Shares of Common Stock underlying Warrants

 

 

This prospectus supplement amends and supplements the prospectus dated April 3,  2015,  as previously supplemented (the “Prospectus”), which forms a part of our Post-Effective Amendment No. 5 to Registration Statement to Form S-3 on Form S-1 (Registration Statement No. 333-166556) that was declared effective on April 3, 2015.  The Prospectus relates to the sale and issuance of up to 3,057,500 shares of common stock of Jones Soda Co. to holders of outstanding warrants, upon exercise of such warrants.

 

On May 7,  2015, we filed with the Securities and Exchange Commission a current report on Form 8-K. This Supplement is being filed to update, amend and supplement the information included or incorporated by reference in the Prospectus with the information contained in the current report on Form 8-K. Accordingly, we have attached the Form 8-K to this Supplement.

 

You should read this Supplement in conjunction with the Prospectus, which is to be delivered with this Supplement. If there is any inconsistency between the information in the Prospectus and this Supplement, you should rely on the information in this Supplement.

 

Investing in our common stock involves a high degree of risk.  See “Risk Factors” beginning on page 3 of the Prospectus for a discussion for the risks associated with our business.  Also see “Cautionary Notice Regarding Forward-Looking Statements” in our annual report on Form 10-K and our latest quarterly report on Form 10-Q.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus or this Supplement is truthful or complete.  Any representation to the contrary is a criminal offense.

 

 

The date of this Prospectus Supplement is May 7, 2015.